Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.83B |
| 2 |
Wells Fargo
WFC
|
+$378M |
| 3 |
Microsoft
MSFT
|
+$253M |
| 4 |
Home Depot
HD
|
+$247M |
| 5 |
Alibaba
BABA
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$414M |
| 2 |
Lowe's Companies
LOW
|
+$326M |
| 3 |
Las Vegas Sands
LVS
|
+$265M |
| 4 |
AABA
Altaba Inc
AABA
|
+$249M |
| 5 |
NBL
Noble Energy, Inc.
NBL
|
+$181M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 10.45% |
| 2 | Technology | 8.65% |
| 3 | Financials | 8.6% |
| 4 | Consumer Discretionary | 7.75% |
| 5 | Industrials | 7.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Norfolk Southern
NSC
$78.8B
| $155M | 0.19% |
800,556
+534,389
| +201% | +$100M |
|
77
Biogen
BIIB
$31.8B
| $154M | 0.19% |
519,614
-134,114
| -21% | -$37.2M |
|
78
Northrop Grumman
NOC
$78.1B
| $153M | 0.19% |
445,976
+313,032
| +235% | +$110M |
|
79
Dollar General
DG
$27.4B
| $152M | 0.19% |
975,401
+291,983
| +43% | +$46.3M |
|
80
PUT
State Street Utilities Select Sector SPDR ETF
XLU
$22B
| $149M | 0.19% |
4,625,000
+2,358,800
| +104% | +$74.9M |
|
|
WCG
81
DELISTED
Wellcare Health Plans, Inc.
WCG
| $149M | 0.19% |
449,909
+84,687
| +23% | +$25.4M |
|
82
CALL
Meta Platforms (Facebook)
META
$1.42T
| $147M | 0.18% |
717,500
+147,800
| +26% | +$28.6M |
|
|
HRC
83
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $147M | 0.18% |
1,294,428
+373,526
| +41% | +$39.4M |
|
84
PUT
Berkshire Hathaway Class B
BRK.B
$1.07T
| $146M | 0.18% |
645,000
+485,000
| +303% | +$105M |
|
85
PUT
iShares US Real Estate ETF
IYR
$4.64B
| $146M | 0.18% |
1,569,000
+185,400
| +13% | +$17.2M |
|
86
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.6B
| $146M | 0.18% |
1,659,500
+1,542,205
| +1,315% | +$134M |
|
|
87
Berkshire Hathaway Class B
BRK.B
$1.07T
| $145M | 0.18% |
638,222
+575,954
| +925% | +$125M |
|
88
Netflix
NFLX
$334B
| $140M | 0.18% |
4,335,490
+2,555,260
| +144% | +$75.8M |
|
89
Union Pacific
UNP
$183B
| $140M | 0.18% |
774,040
-454,236
| -37% | -$77.8M |
|
90
United Airlines
UAL
$36.9B
| $140M | 0.17% |
1,585,663
+41,883
| +3% | +$3.76M |
|
91
PUT
Micron Technology
MU
$1.03T
| $137M | 0.17% |
2,553,200
+680,500
| +36% | +$32.5M |
|
92
PUT
State Street SPDR S&P Regional Banking ETF
KRE
$4.07B
| $137M | 0.17% |
2,348,700
+656,100
| +39% | +$36.4M |
|
93
PUT
Bristol-Myers Squibb
BMY
$137B
| $135M | 0.17% |
2,104,600
+1,142,300
| +119% | +$65.4M |
|
94
Visa
V
$711B
| $132M | 0.17% |
704,082
-423,743
| -38% | -$76.3M |
|
|
CZR
95
DELISTED
Caesars Entertainment Corporation
CZR
| $131M | 0.16% |
9,596,958
+1,358,172
| +16% | +$17.2M |
|
96
Merck
MRK
$373B
| $130M | 0.16% |
1,492,240
+1,428,796
| +2,252% | +$117M |
|
|
WPX
97
DELISTED
WPX Energy, Inc.
WPX
| $129M | 0.16% |
9,421,073
+1,771,754
| +23% | +$18.9M |
|
98
PUT
Walmart Inc
WMT
$835B
| $129M | 0.16% |
3,259,800
+1,329,900
| +69% | +$52.8M |
|
99
Global Payments
GPN
$25.2B
| $128M | 0.16% |
701,540
+247,913
| +55% | +$42.6M |
|
100
McDonald's
MCD
$193B
| $128M | 0.16% |
646,505
+622,095
| +2,549% | +$123M |
|
Similar funds
Israel Englander's Q4 2019 Portfolio in Review
As of Q4 2019, Israel Englander held 4,935 positions worth $79.9B, up 26% from $63.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Israel Englander deployed $9.74B of net new capital in Q4 2019, opening 829 new positions and adding to 1,631 existing holdings. Its largest new stake was International Flavors & Fragrances: 535,214 shares worth $69.1M.
By sector, the portfolio is most concentrated in Healthcare at 10% of assets, down from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Lowe's Companies, an estimated $326M trimmed.
- Israel Englander's largest Q4 2019 buy was International Flavors & Fragrances: 535,214 shares worth $69.1M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $3.83B increase.
- Israel Englander's biggest Q4 2019 reduction was Lowe's Companies, cutting an estimated $326M.
- Israel Englander fully exited Celgene Corp in Q4 2019, selling an estimated $414M.
- Israel Englander's ten largest holdings make up 13% of its $79.9B portfolio in Q4 2019.
- Israel Englander opened 829 new positions and closed 796 in Q4 2019.
- Israel Englander's portfolio value rose 26% quarter-over-quarter to $79.9B.
Based on Millennium Management's 13F filing for Q4 2019, filed 14 Feb 2020.